Study: Surgery Generally More Cost-Effective Than Radiation for Prostate Cancer
British Journal of Urology International.
The researchers aimed to determine the differences in outcomes and costs for various prostate cancer treatments, including radical prostatectomy (open, laparoscopic or robot-assisted) and radiation therapy (dose-escalated three-dimensional conformal RT, intensity-modulated RT, brachytherapy or combination).
The researchers used a model to determine the probable outcomes of primary treatment for hypothetical men with low-, intermediate- and high-risk localized prostate cancer. The authors based probabilities on a literature search of 232 publications and they determined costs from the USA payor perspective.
Results showed only slight differences in quality-adjusted life years across all treatment types. Surgical methods were generally more effective than RT methods, except for combined external beam and brachytherapy for high-risk disease.
However, there was a wide range of costs, spanning from $19,901 for robot-assisted prostatectomy for low-risk disease to $50,276 for combined RT for high-risk disease.
More Articles on Healthcare Cost and Quality:Study: Link Between Healthcare Cost, Quality is Unclear
6-Step Prescription for Quality Improvement in Low-Resource Areas
Patient Navigation Can Help Hospitals Reach Quality, Cost Goals
© Copyright ASC COMMUNICATIONS 2014. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
New From Becker's Infection Control & Clinical Quality
The qualified clinical data registry: A primer for outpatient providersRead Now
- 12 tips to negotiate a deal more effectively
- ASC stock report — 5 key company updates
- New EndoChoice slim scope, US Endoscopy distribution agreement & more – 6 GI/endoscopy company key notes
- VisionCare completes financing for commercialization of telescope implant
- House committee chairmen release joint statement on ICD-10 implementation